North America, led by the United States and supported by Canada, holds a dominant position in the global protein therapeutics industry due to its strong healthcare infrastructure and early adoption of advanced biologics. The region benefits from high healthcare expenditure, well-established biopharmaceutical manufacturing capabilities, and extensive research collaborations between academic...